Skip to main content

Rydym wedi cadw rhai ffeiliau o'r enw cwcis ar eich dyfais. Y cwcis hyn yw:

  • Hanfodol ar gyfer y safle i weithio
  • Helpu i wella ein gwefan drwy gasglu ac adrodd gwybodaeth am sut rydych chi'n ei defnyddio

Hoffem hefyd arbed rhai cwcis i helpu i deilwra cyfathrebu.

BETA
Rydych yn edrych ar fersiwn wedi'i ddiweddaru o'r gwasanaeth hwn - bydd eich adborth yn ein helpu i'w wella.

Hysbysiad o Ddyfarnu Contract

Investment Management Services

  • Cyhoeddwyd gyntaf: 28 Medi 2023
  • Wedi'i addasu ddiwethaf: 28 Medi 2023
  • Fersiwn: N/A
  •  

  • Efallai na fydd y ffeil hon yn gwbl hygyrch.

  •  

Eicon Gwybodaeth

Nid yw'r prynwr yn defnyddio'r wefan hon i weinyddu'r hysbysiad.

I gofnodi eich diddordeb neu gael gwybodaeth neu ddogfennau ychwanegol, darllenwch y cyfarwyddiadau yn Nhestun Llawn yr Hysbysiad. (NODER: Nid oes angen ymateb i Hysbysiadau Dyfarnu Contractau a Hysbysiadau Gwybodaeth Ymlaen Llaw fel arfer)

Cynnwys

Crynodeb

OCID:
ocds-kuma6s-134078
Cyhoeddwyd gan:
Cancer Research Wales
ID Awudurdod:
AA84312
Dyddiad cyhoeddi:
28 Medi 2023
Dyddiad Cau:
-
Math o hysbysiad:
Hysbysiad o Ddyfarnu Contract
Mae ganddo ddogfennau:
Nac Ydi
Wedi SPD:
Nac Ydi
Mae ganddo gynllun lleihau carbon:
Nac Ydi

Crynodeb

3.1 CRW has an investment portfolio as at 31 March 2023 of £4.5 million invested within the ethical markets. 3.2 As a Cancer Research Charity, investments in any tobacco related products is prohibited and this is a non negotiable condition. 3.3 The investment portfolio is held to provide a financial return in the form of interest receivable and investment gains to fund our Research Strategy 3.4 The appointed supplier will be responsible for, but shall not be limited to: I. Reviewing the current Investment Policy and making recommendations as appropriate.. II. Make investment decisions in line with the Investment Policy. III. Provide Quarterly reviews and an annual review of the Investment Portfolio IV. Provide relevant information to enable the preparation of the Charities Financial Statements V. Act as a sounding board and advisor. VI. Actively engage in the activities of the Charity to understand the work we do, challenges and opportunities.

Testun llawn y rhybydd

HYSBYSIAD O DDYFARNU CONTRACT - CENEDLAETHOL

SERVICES

1 Manylion yr Awdurdod

1.1

Enw a Chyfeiriad yr Awdurdod


Cancer Research Wales

Unit 22, Neptune Court, Vanguard Way,

Cardiff

CF245PJ

UK

Alison Yandall

+44 07365206564


https://www.cancerresearch.wales

2 Manylion y Contract

2.1

Teitl

Investment Management Services

2.2

Disgrifiad o'r contract

3.1 CRW has an investment portfolio as at 31 March 2023 of £4.5 million invested within the ethical markets.

3.2 As a Cancer Research Charity, investments in any tobacco related products is prohibited and this is a non negotiable condition.

3.3 The investment portfolio is held to provide a financial return in the form of interest receivable and investment gains to fund our Research Strategy

3.4 The appointed supplier will be responsible for, but shall not be limited to:

I. Reviewing the current Investment Policy and making recommendations as appropriate..

II. Make investment decisions in line with the Investment Policy.

III. Provide Quarterly reviews and an annual review of the Investment Portfolio

IV. Provide relevant information to enable the preparation of the Charities Financial Statements

V. Act as a sounding board and advisor.

VI. Actively engage in the activities of the Charity to understand the work we do, challenges and opportunities.

2.3

Cod a Dosbarthiad yr Hysbysiad

66100000 Banking and investment services
66600000 Treasury services
79220000 Fiscal services
79412000 Financial management consultancy services
1022 Cardiff and Vale of Glamorgan

2.4

Amcangyfrif o Gyfanswm Gwerth

3 Gweithdrefn

3.1

Math o Weithdrefn

Un cam

4 Dyfarnu Contract

4.1

Cynigwyr Llwyddiannus

4.1.1

Enw a Chyfeiriad y cyflenwr, contractwr neu ddarparwr gwasanaeth llwyddiannus





Brewin Dolphin Limited

5 Callaghan Square, 2Nd Floor,

Cardiff

CF105BT

UK

Paul Mathias



https://www.brewin.co.uk/cardiff

5 Gwybodaeth Arall

5.1

Rhif cyfeirnod a roddwyd i'r hysbysiad gan yr awdurdod contractio

CRW2023-01

5.2

Dyddiad Dyfarnu'r Contract

  28 - 09 - 2023

5.3

Nifer y tendrau a dderbyniwyd

7

5.4

Gwybodaeth Arall

(WA Ref:135192)

5.5

Dogfennaeth Ychwanegol

Dd/g

5.6

Dyddiad cyhoeddi'r hysbysiad hwn:

  28 - 09 - 2023

Codio

Categorïau nwyddau

ID Teitl Prif gategori
66100000 Gwasanaethau bancio a buddsoddi Gwasanaethau ariannol ac yswiriant
79220000 Gwasanaethau cyllidol Gwasanaethau cyfrifyddu, archwilio a chyllidol
66600000 Gwasanaethau trysorfa Gwasanaethau ariannol ac yswiriant
79412000 Gwasanaethau ymgynghori ar reoli arian Gwasanaethau ymgynghori ar fusnes a rheoli

Lleoliadau Dosbarthu

ID Disgrifiad
1022 Caerdydd a Bro Morgannwg

Cyfyngiadau Rhanbarthol ar y Rhybuddion

Mae’r prynwr wedi cyfyngu’r rhybuddion ar gyfer yr hysbysiad hwn i gyflenwyr yn y rhanbarthau canlynol.

ID Disgrifiad
Nid oes cyfyngiadau ar y rhybuddion ar gyfer yr hysbysiad hwn.

Teulu dogfennau

Manylion hysbysiad
Dyddiad cyhoeddi:
15 Awst 2023
Dyddiad Cau:
06 Medi 2023 00:00
Math o hysbysiad:
Hysbysiad o Gontract
Enw Awdurdod:
Cancer Research Wales
Dyddiad cyhoeddi:
28 Medi 2023
Math o hysbysiad:
Hysbysiad o Ddyfarnu Contract
Enw Awdurdod:
Cancer Research Wales

Ynglŷn â'r prynwr

Prif gyswllt:
N/a
Cyswllt gweinyddol:
N/a
Cyswllt technegol:
N/a
Cyswllt arall:
N/a

Gwybodaeth bellach

Dyddiad Manylion
Nid oes unrhyw wybodaeth bellach wedi'i lanlwytho.

0800 222 9004

Mae'r llinellau ar agor rhwng 8:30am a 5pm o ddydd Llun i ddydd Gwener.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.